Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Aug 15, 2026; 18(8): 119026
Published online Aug 15, 2026. doi: 10.4251/wjgo.119026
Published online Aug 15, 2026. doi: 10.4251/wjgo.119026
Table 1 Comparison of general characteristics among patients with different diseases, mean ± SD/n (%)
| Group | n | Gender (male/female) | Age (years) | BMI (kg/m2) | Helicobacter pylori positivity |
| Erosive gastritis group | 45 | 23 (51.11)/22 (48.89) | 50.66 ± 5.31 | 22.87 ± 3.02 | 13 (28.89) |
| Gastrointestinal polyp group | 14 | 7 (50.00)/7 (50.00) | 55.49 ± 5.78 | 23.04 ± 2.95 | 4 (28.57) |
| Peptic ulcer group | 24 | 10 (41.67)/14 (58.33) | 52.41 ± 5.02 | 23.22 ± 3.08 | 6 (25.00) |
| Gastrointestinal tumor group | 10 | 4 (40.00)/6 (60.00) | 66.20 ± 6.97a | 22.41 ± 2.90 | 3 (30.00) |
| F/χ2 | - | 0.831 | 9.32 | 0.176 | 0.154 |
| P value | - | 0.843 | < 0.001 | 0.913 | 0.991 |
Table 2 Comparison of Streptococcus pharyngitidis positivity rate and relative bacterial load among patients with different gastrointestinal diseases, n (%)
Table 3 Comparison of Streptococcus pharyngitidis positivity rates and bacterial load in different anatomical sites among patients with various gastrointestinal diseases, n (%)/median (interquartile range)
| Group | n | Lesional mucosa positivity | Distal mucosa positivity | Gastric juice/feces positivity | Relative bacterial load (lesional mucosa, 2-ΔΔCt) | Relative bacterial load (distal mucosa, 2-ΔΔCt) | Relative bacterial load (gastric juice/feces, 2-ΔΔCt) |
| Erosive gastritis group | 45 | 6 (13.33) | 3 (6.67) | 4 (8.87) | 0.18 (0.10, 0.32) | 0.12 (0.06, 0.25) | 0.16 (0.09, 0.28) |
| Gastrointestinal polyp group | 14 | 4 (28.57) | 1 (7.14) | 2 (14.29) | 0.34 (0.20, 0.55) | 0.21 (0.12, 0.39) | 0.30 (0.18, 0.48) |
| Peptic ulcer group | 24 | 7 (29.17) | 5 (20.83) | 6 (25.00) | 0.36 (0.22, 0.60) | 0.24 (0.18, 0.41) | 0.32 (0.20, 0.50) |
| Gastrointestinal tumor group | 10 | 8 (80.00)a | 6 (60.00) | 5 (50.00) | 0.92 (0.65, 1.35)a,b | 0.61 (0.42, 1.06)a | 0.82 (0.55, 1.20)a |
| χ2/H | - | 10.213 | 7.86 | 8.40 | 44.0 | 38.6 | 42.7 |
| P value | - | 0.017 | 0.044 | 0.038 | < 0.001 | < 0.001 | < 0.001 |
Table 4 Comparison of Streptococcus pharyngitidis positivity rates among patients with different clinical-pathological characteristics, n (%)
| Clinicopathological characteristics | n = 10 | S. anginosus | P value | |
| Positive | Negative | |||
| Degree of mucosal inflammation | < 0.0011 | |||
| Mild-moderate | 6 | 3 (50.00) | 3 (50.00) | |
| Severe | 4 | 4 (100.00) | 0 (0.00) | |
| TNM staging | < 0.0011 | |||
| Stage I-II | 6 | 2 (50.00) | 4 (50.00) | |
| Stage III-IV | 4 | 4 (100.00) | 0 (0.00) | |
| Lymph node metastasis | < 0.0011 | |||
| Present | 3 | 3 (100.00) | 0 (0.001) | |
| Absent | 7 | 3 (42.86) | 4 (57.14) | |
Table 5 Correlation between relative bacterial load of Streptococcus pharyngitidis and pathological characteristics in patients with gastrointestinal tumors
| Pathological characteristics | Relative bacterial load of S. anginosus | |
| r value | P value | |
| Mucosal inflammation score | 0.436 | < 0.001 |
| Tumor invasion depth | 0.382 | < 0.001 |
Table 6 Multivariate analysis of factors affecting gastrointestinal tumors
| Factors | β | SE | χ² | OR | 95%CI | P value |
| Gender | -2.008 | 0.500 | 6.746 | 0.135 | 0.050-0.358 | 0.744 |
| Age | 1.890 | 0.609 | 11.029 | 1.389 | 1.642-2.598 | 0.004 |
| Smoking | -2.000 | 0.509 | 6.841 | 0.139 | 0.113-0.161 | 0.722 |
| Alcohol consumption | -2.011 | 0.513 | 6.802 | 0.135 | 0.049-0.366 | 0.613 |
| S. anginosus positivity | 1.486 | 0.736 | 14.539 | 2.385 | 1.846-5.102 | < 0.001 |
| Helicobacter pylori infection | -2.015 | 0.510 | 6.940 | 0.133 | 0.049-0.362 | 0.849 |
Table 7 Comparison of tumor burden between different model groups, mean ± SD
| Group | Tumor nodules (n) | Maximum diameter (mm) | Tumor volume (mm3) | Tumor weight (g) |
| Normal control group (n = 5) | 0.11 ± 0.02 | - | - | - |
| Gastric cancer model group (n = 5) | 4.62 ± 0.21a | 6.85 ± 0.66 | 185.46 ± 16.22 | 0.86 ± 0.02 |
| Gastric cancer + S. anginosus intervention group (n = 5) | 6.28 ± 0.36a,b | 8.41 ± 0.52 | 248.63 ± 20.17 | 1.17 ± 0.09 |
| F/t value | 878.8 | 4.152 | 5.463 | 7.518 |
| P value | < 0.001 | 0.003 | 0.001 | < 0.001 |
Table 8 Comparison of serum interleukin-6 and tumor necrosis factor-α levels between different model groups, mean ± SD
Table 9 Comparison of immune cell infiltration between different model groups, mean ± SD
| Group | CD4+ T | CD8+ T | CD68+ macrophages |
| Normal control group (n = 5) | 8.42 ± 3.14 | 6.58 ± 1.16 | 5.87 ± 0.74 |
| Gastric cancer model group (n = 5) | 24.68 ± 6.22a | 18.74 ± 2.52a | 22.18 ± 3.06a |
| Gastric cancer + S. anginosus intervention group (n = 5) | 36.55 ± 7.51a,b | 26.47 ± 3.44a,b | 29.85 ± 3.71a,b |
| F value | 28.50 | 77.22 | 95.02 |
| P value | < 0.001 | < 0.001 | < 0.001 |
Table 10 Relationship between relative bacterial load of pharyngitis streptococcus and serum interleukin-6, tumor necrosis factor-α levels, and immune cell infiltration score
| Indicators | Relative bacterial load of S. anginosus | |
| r value | P value | |
| IL-6 | 0.458 | < 0.001 |
| TNF-α | 0.469 | < 0.001 |
| CD4+ T cell infiltration score | 0.587 | < 0.001 |
| CD8+ T cell infiltration score | 0.506 | < 0.001 |
| CD68+ macrophage infiltration score | 0.545 | < 0.001 |
- Citation: Huang DB, Chen BS, Wang AP, Hu XZ, Xu YJ. Polymerase chain reaction detection of Streptococcus anginosus in digestive diseases and its immunomodulation in rat gastric cancer model. World J Gastrointest Oncol 2026; 18(8): 119026
- URL: https://www.wjgnet.com/1948-5204/full/v18/i8/119026.htm
- DOI: https://dx.doi.org/10.4251/wjgo.119026